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Abstract
Background—Pregnant women are at risk of severe influenza disease and are a priority group 
for influenza vaccination programs. Nicaragua expanded recommendations to include influenza 
vaccination to all pregnant women in the municipality of Managua in 2013.
Methods—We carried out a survey among 1,807 pregnant women who delivered at public 
hospitals in the municipality of Managua to evaluate the uptake of influenza vaccination and 
factors associated with vaccination.
Results—We observed a high (71%) uptake of influenza vaccination among this population, with 
no differences observed by age, education or parity of the women. Having four antenatal visits and 
five or more visits were associated with receipt of influenza vaccination (AORs: 2.58; 95% CI: 
1.15, 5.81, and 2.37; 95% CI: 1.12, 5.0, respectively). Also, receipt of influenza vaccination 
recommendation from a health care provider was positively associated with receipt of influenza 
vaccination (AOR: 14.22; 95% CI: 10.45, 19.33).
Conclusions—The successful expansion of influenza vaccination among pregnant women in the 
municipality of Managua may be due to ready access to free medical care and health care 
providers’ recommendation for vaccination at health care clinics that received influenza vaccine.
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Pregnant women who become ill with an influenza virus infection are at high-risk of 
developing influenza complications, including hospitalization [1–4]. Influenza vaccination 
has been shown to offer preventive benefits for the mother; the fetus; and children up to 6 
months of age, who are not yet recommended to receive influenza vaccination [5–8]. Thus, 
in 2012, the Technical Advisory Group (TAG) of the Pan American Health Organization and 
the Strategic Advisory Group of Experts (SAGE) on Immunization of the World Health 
Organization recommended including pregnant women in the priority group for influenza 
vaccination [9,10].
In 2007, with Government funding, Nicaragua first introduced influenza vaccination into the 
national vaccination schedule, targeting adults 50 years and older and children less than 2 
years old with certain underlying diseases. During the 2009 pandemic, vaccination with 
monovalent pandemic (H1N1) influenza vaccine was extended to persons with chronic 
diseases and to women with high-risk pregnancies [11]. Nicaragua was among the Latin 
American countries with the highest coverage (88.1%) of pandemic influenza vaccination 
for women with high-risk pregnancies [12].
In 2013, the Nicaraguan Ministry of Health, with support from the Partnership for Influenza 
Vaccine Introduction (PIVI) – a collaborative project that includes participation from the 
Centers for Disease Control and Prevention (CDC), the Pan American Health Organization 
(PAHO) and the Task Force for Global Health – piloted for the expansion of influenza 
vaccination to include all pregnant women in the capital city of Managua and the 
surrounding municipality. Influenza vaccine was distributed by the National Immunization 
Program and was recommended and offered to pregnant women at their routine antenatal 
visits at local health care clinics. Various studies in other countries indicate that receiving 
influenza vaccination recommendations from health care personnel and information about 
the benefits of vaccination increases vaccination acceptance among pregnant women [13–
15]. Nonetheless, uptake of influenza vaccine among pregnant women has varied across 
studies, with lower coverage observed in certain demographic subgroups, such as racial 
minorities in North America [16,17].
This article aims to describe the acceptability of influenza vaccination in the context of 
expanded access to all pregnant women residing in the municipality of Managua. In 
addition, we investigate if participant and antenatal care characteristics, and health care 
providers’ recommendation for vaccination are associated with receipt of the vaccine.
2. Methods
Nicaragua launched influenza vaccination and recommendation for all pregnant women in 
the capital city of Managua and the surrounding municipality in July 2013. Between October 
and December 2013, a convenience sample of 1807 of approximately 3700 women were 
interviewed when they delivered their infant(s) at Hospital Bertha Calderon Roque and 
Hospital Fernando Velez Paiz, two large Managua public hospitals out of three with 
parturition services. Women who did not reside within the municipality of Managua were 
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excluded, since vaccination access was limited during this time to pregnant women in 
Managua. The standardized questionnaire included information on demographics, antenatal 
care, all vaccinations received during pregnancy and reasons for influenza vaccination. Self-
reported vaccination status was used for the base analyses; however, self-reported data was 
corroborated via vaccination cards and/or antenatal medical records when available. Similar 
to previous studies of this population [18], age was categorized into three groups: <18, 18–
34, and ≥35 years. Additional participant characteristics (race, district of residence within 
the municipality of Managua, education, employment, number of children) and antenatal 
care characteristics (single vs multiple pregnancy, number of antenatal visits, consumption 
of antenatal supplements, at least one tetanus vaccine dose received in most recent 
pregnancy, and influenza vaccination) were examined, as were reasons for receiving or not 
receiving influenza vaccination.
Similar to previous studies [17,19,20], we analyzed by bivariate and multivariate analyses 
the relationship of participant characteristics (age, race, district, education, employment, 
number of children), antenatal care characteristics (single vs multiple pregnancy, number of 
antenatal visits, consumption of antenatal supplements and at least one tetanus vaccine dose 
received in most recent pregnancy) and receipt of influenza vaccination recommendation 
from health care provider with self-reported receipt of influenza vaccine. In sensitivity 
analyses, we repeated these analyses excluding those who lacked vaccination cards or 
medical records. We present unadjusted and adjusted odds ratios (ORs and AORs) with 95% 
confidence intervals. All analyses were performed using R software (version 3.0.2).
2.1. Ethics statement
This study was considered public health practice and not considered to be human subjects’ 
research in accordance with federal human subjects’ protection regulations. The study was 
approved by the institutional review board at the Nicaraguan Ministry of Health.
3. Results
Over three-quarters of participants in this survey were between 18 and 34 years old, mixed 
race, housewives and had either a primary or a secondary school education (Table 1). 
Approximately two thirds (65%) of women reported having at least one other child prior to 
this pregnancy. Nearly all women (99%) reported attending at least one antenatal visit, 73% 
reported more than four antenatal visits; 98% reported taking antenatal supplements during 
pregnancy. Seventy-one percent of women reported receiving influenza vaccination at any 
time in their pregnancy, and 84% reported receiving at least one dose of tetanus vaccination 
during their most recent pregnancy. Approximately half (54%) of the participants had 
vaccination cards or medical records which could be used to document their vaccination 
status; self-reported influenza vaccine recipients were more likely than self-reported 
unvaccinated women to have vaccination cards or medical records available (63% vs 31%, 
respectively, p < 0.01).
No association was observed between the receipt of influenza vaccine during pregnancy and 
age, race, district of residence, education, employment, number of children, and single vs 
multiple pregnancy in either the unadjusted and adjusted models (Table 2). However, the 
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number of antenatal visits and receipt of influenza vaccination recommendation from a 
health care provider were associated with receipt of influenza vaccination and these bivariate 
associations persisted in a multivariate model that adjusted for participant and antenatal care 
characteristics (p-values <0.01); the association between receipt of influenza vaccination 
recommendation and vaccination also persisted when the sample was limited to those with 
vaccination documentation (from vaccination cards or medical records) (data not shown). 
Specifically, having four antenatal visits and five or more visits were associated with receipt 
of influenza vaccination comparing to one antenatal visit only (AOR: 2.58; 95% CI: 1.15, 
5.81 and AOR: 2.37; 95% CI: 1.12, 5.0, respectively) in the adjusted model. For those who 
received an influenza vaccination recommendation from a health care provider, the adjusted 
odds of receiving influenza vaccination increased by a factor of 14.22 (95% CI: 10.45, 
18.40; Table 2).
Women who received influenza vaccination recommendation from a health care provider 
were more likely to be vaccinated against influenza compared to those who did not receive a 
recommendation (82% vs 24%, p < 0.01). Reasons reported for not receiving influenza 
vaccination included: 44% (234/527) did not receive information about influenza 
vaccination, 10% (53/527) were not offered influenza vaccination, and 2% (12/527) reported 
accessibility problems (e.g. transportation, distance); one participant reported not trusting 
vaccines as a reason for refusal.
4. Discussion
The uptake of influenza vaccination at its introduction to all pregnant women in Managua, 
Nicaragua observed in this study was 71%. This is higher than influenza vaccination rates 
among pregnant women in countries that have been vaccinating pregnant women against 
influenza for several years [16,21–23]. For instance, influenza vaccination coverage among 
pregnant women in the United States increased from around 10% in 2001–2002 season to 
50% in 2010–2011 season [24]. The results from this study are consistent with high rates of 
vaccination among high-risk pregnant women in Nicaragua achieved during the 2009 
influenza pandemic [12].
The successful uptake of influenza vaccination among pregnant women who delivered at 
public hospitals in the municipality of Managua, as well as the high percentage of pregnant 
women with at least one antenatal visit, is likely due to ready access to free medical care and 
influenza vaccination recommendation from health care providers. The Nicaraguan Ministry 
of Health has developed a family and community health model which prioritizes access to 
antenatal care and maternal immunizations [25]. Under this framework, health centers 
conduct a maternity census every year and pregnant women are followed-up and encouraged 
to receive health care during pregnancy, which has led to high number of women who had at 
least one antenatal visit (99%) and more than four antenatal visits (73%). Since 2007, health 
centers have implemented influenza vaccination strategies such as conducting house-to-
house vaccination before influenza vaccine is set to expire to reduce vaccine wastage and 
designating physical space to receive patients seeking influenza vaccination who have been 
referred from smaller health units that do not provide influenza vaccination.
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Antenatal visits are key to promoting the benefits of influenza vaccination and offering 
vaccination to pregnant women [20]. Scheminske et al. showed higher rates of vaccination in 
women who engage in healthy behaviors during pregnancy [26]. In this study having four or 
more antenatal visits, a proxy for engaging in healthy behaviors, was associated with receipt 
of vaccination. Our results are also consistent with a number of studies that show a higher 
influenza vaccination rate among pregnant women when they received a recommendation 
from their doctor [13–15,20,27,28]. In contrast to other studies [14,29–31], the most 
frequently reported reason for not receiving influenza vaccination was not related to safety 
concerns but rather not receiving information or recommendation regarding influenza 
vaccination. Interestingly, we did not find an interaction between the number of antenatal 
visits and receipt of vaccination recommendation in regard to vaccination (data not shown). 
We speculate that there might be unmeasured factors such as availability of vaccine at health 
units or vaccination offer that could describe better these relationships.
Unlike other studies in North America and Europe, however, we did not observe a 
relationship between participant characteristics (age, race, education, employment, number 
of children) and receipt of influenza vaccination during pregnancy [17,19,32]. However, 
Henninger et al. [28] showed that demographic characteristics that were significantly 
associated with vaccination in univariate analyses became no longer significant after 
controlling for health beliefs about vaccination, which is consistent with that we observed. 
In addition, Bingham et al found a higher user acceptability of government-sponsored 
immunization programs in middle- and low-income countries [33], which seems to be the 
case in Nicaragua.
This study has at least three limitations. First, the study population may only represent 
women who deliver at the two study hospitals. Although we covered approximately 49% of 
women who delivered in these hospitals and even though these two hospitals covered 
approximately 70% of deliveries in the municipality of Managua [34], the study sample was 
not randomly selected but rather a convenience sample and the extent to which our findings 
generalize to all pregnant women in this region is unknown. Second, about half of the 
sample lacked written documentation of influenza vaccination status. According to Jimenez-
Garcia et al. [35], self-reported influenza vaccination tends to overestimate vaccination 
coverage. This study aimed to overcome this bias by corroborating self-reported influenza 
vaccination with vaccination registries; thus, increasing the quality of the study. Then, 
although self-report of vaccination was potentially subject to social desirability and recall 
biases, we were reassured about our results when we observed similar findings from analysis 
of a subsample that included only those with written documentation of vaccination. Third, 
our study did not contain all variables of potential interest; most notably, our study would 
have benefited from including information on smoking, alcohol consumption and marital 
status, which have been shown to be associated with influenza vaccination coverage in prior 
studies [17].
In summary, influenza vaccination and recommendation expanded to all pregnant women in 
the municipality of Managua was well received, which may be due to the Nicaraguan 
Ministry of Health strategy to prioritize access to health care to families and communities. 
Nonetheless, there continues to be room for further vaccination promotion. Our findings 
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suggest that increasing clinician recommendations of the vaccine and more discussion of the 
benefits of influenza vaccination could increase uptake. Since influenza vaccine uptake was 
lower among women with fewer antenatal visits, other strategies may be needed to reach 
women outside of antenatal care or to incorporate influenza vaccination into other programs 
that focus on the most vulnerable pregnant women.
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Table 1
Participant and antenatal care characteristics of pregnant women in the Managua Municipality, interviews at 
delivery (n = 1807), Nicaragua, October 2013–December 2013.
Participant characteristics Pregnant women
n = 1807 n (%)
Age
  <18 years 204 (11.3%)
  18–34 years 1478 (81.8%)
  ≥35 years 125 (6.9%)
Race
  White 113 (6.3%)
  Mixed 1585 (87.7%)
  Black 109 (6.0%)
District, Managua Municipality
  I 277 (15.3%)
  II 283 (15.7%)
  III 440 (24.3%)
  IV 181 (10.0%)
  V 378 (20.9%)
  VI 130 (7.2%)
  VII 118 (6.5%)
Education
  None 35 (1.9%)
  Incomplete primary school 210 (11.6%0
  Completed primary school 173 (9.6%)
  Incomplete secondary school 608 (33.6%)
  Completed secondary school 507 (28.1%)
  Technical education 106 (5.9%)
  University studies 168 (9.3%)
Employment
  Housewife 1449 (80.2%)
  Technical work 150 (8.3%)
  Professional work 145 (8.0%)
  Other 63 (3.5%)
Number of children
  0 608 (33.6%)
  1 637 (35.3%)
  2 318 (17.6%)
  ≥3 244 (13.5%)
Prenatal Care characteristics
Type of pregnancy
  Single 1784 (98.7%)
  Multiple 23 (1.3%)
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Participant characteristics Pregnant women
n = 1807 n (%)
Number of antenatal visits
  0 22 (1.2%)
  1 43 (2.4%)
  2 72 (4.0%)
  3 132 (7.3%)
  4 213 (11.8%)
  ≥5 1325 (73.3%)
Consumption of antenatal supplements (iron, folic acid, multivitamins, calcium)
  Yes 1774 (98.2%)
  No 33 (1.8%)
Number of tetanus vaccine doses received in most recent pregnancy
  0 291 (16.1%)
  ≥1 1516 (83.9%)
Received influenza vaccination**
  Yes 1280 (70.8%)
    Documented by vaccination card and/or medical records 809 (63.2%)
  No 527 (29.2%)
    Documented by vaccination card and/or medical records 163 (30.9%)
**
Self-reported and confirmed influenza vaccination status by documented vaccination records (vaccination card, antenatal control form).
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Table 2
Relationship between participant and antenatal care characteristics and influenza vaccination during 
pregnancy, bivariate and multivariable analysis, Managua Municipality, Nicaragua, October 2013–December 
2013.
Self-reported vaccinated (1 = Yes; 0 = No)
Variables Unadjusted OR 95% CI Adjusted OR** 95% CI
Age (Ref = 18–34 years)
  <18 vs Ref 0.73 (0.54, 1.0) 0.76 (0.51, 1.12)
  ≥35 vs Ref 0.80 (0.54, 1.18) 0.81 (0.49, 1.35)
Race (Ref = White)
  Mixed vs Ref 1.33 (0.89, 1.98) 1.14 (0.70, 1.86)
  Black vs Ref 1.03 (0.59, 1.79) 1.44 (0.73, 2.82)
District, Managua Municipality (Ref = District I)
  District II vs Ref 1.50 (1.03, 2.18) 1.29 (0.84, 2.0)
  District III vs Ref 1.06 (0.77, 1.47) 1.11 (0.75, 1.62)
  District IV vs Ref 1.22 (0.81, 1.84) 1.08 (0.67, 1.76)
  District V vs Ref 1.19 (0.85, 1.68) 1.16 (0.78, 1.73)
  District VI vs Ref 0.94 (0.60,1.47) 1.10 (0.65, 1.88)
  District VII vs Ref 0.94 (0.60, 1.49) 1.34 (0.76, 2.36)
Education (Ref = None)
  Incomplete primary school vs Ref 1.41 (0.67, 2.98) 0.74 (0.29, 1.92)
  Completed primary school vs Ref 1.30 (0.61, 2.78) 0.57 (0.22, 1.49)
  Incomplete secondary school vs Ref 1.38 (0.68, 2.81) 0.73 (0.29, 1.80)
  Completed secondary school vs Ref 1.60 (0.78, 3.26) 0.75 (0.30, 1.88)
  Technical education vs Ref 1.43 (0.64, 3.19) 0.60 (0.22, 1.67)
  University studies vs Ref 1.48 (0.69, 3.17) 0.70 (0.26, 1.92)
Employment (Ref = Housewife)
  Technical work vs Ref 0.76 (0.53, 1.08) 0.94 (0.61, 1.47)
  Professional work vs Ref 1.17 (0.79, 1.73) 1.10 (0.66, 1.85)
  Other vs Ref 0.70 (0.41, 1.18) 0.85 (0.45, 1.61)
Number of children (Ref = 0)
  1 vs Ref 1.04 (0.82,1.33) 1.24 (0.92, 1.68)
  2 vs Ref 0.90 (0.67,1.21) 1.18 (0.81, 1.72)
  3 vs Ref 0.95 (0.69,1.32) 1.30 (0.83, 2.04)
Type of pregnancy (Multiple vs single) 1.97 (0.67,5.82) 2.50 (0.72, 8.73)
Number of antenatal visits (Ref = 1)
  0 vs Ref 0.37 (0.12, 1.19) 1.66 (0.31, 8.96)
  2 vs Ref 1.34 (0.63,2.85) 0.93 (0.37, 2.30)
  3 vs Ref 1.71 (0.86,3.43) 1.25 (0.54, 2.89)
  4 vs Ref 2.94 (1.51,5.74)* 2.58 (1.15, 5.81)*
  ≥5 vs Ref 3.79 (2.05,7.01)* 2.37 (1.12, 5.0)*
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Self-reported vaccinated (1 = Yes; 0 = No)
Variables Unadjusted OR 95% CI Adjusted OR** 95% CI
Consumption of antenatal supplements (Yes vs no) 7.92 (3.55,17.67)* 2.47 (0.70, 8.77)
At least one tetanus vaccine doses received in most recent 
pregnancy (yes vs no)
2.28 (1.76,2.95)* 0.99 (0.71, 1.39)
Received in.uenza vaccination recommendation from provider 
(yes vs no)




Adjusted for age, race, district, education, employment, number of children, type of pregnancy, number of antenatal visits, consumption of 
supplements, number of tetanus vaccine doses received and receipt of influenza vaccination recommendation from provider.
‡
Receipt of influenza vaccination recommendation from provider remained significant when the data was limited to those with documented 
vaccination records (vaccination card, antenatal control form) only (data not shown) (n = 972).
Vaccine. Author manuscript; available in PMC 2017 November 22.
